AXQ Capital LP Makes New Investment in O’Reilly Automotive, Inc. $ORLY

AXQ Capital disclosed a new Q2 stake in O’Reilly Automotive of 13,488 shares worth about $1.22 million, joining several other small institutional purchases as institutions now own roughly 85% of the stock; shares opened at $100.43 with a market cap of $84.8bn, a P/E of 34.8, PEG 2.48, beta 0.57 and a 52-week range of $78.30–$108.71 (50-day/200-day MAs $100.62/$97.33). Insider activity included Director John R. Murphy selling 3,125 shares on Nov. 4 (a 27.78% reduction in his holding), while analysts have largely trended positive—DA Davidson and Goldman Sachs raised targets (to $115 and $121 respectively), Raymond James upgraded to outperform, and MarketBeat’s consensus is a “Moderate Buy” with a $111.89 target—signals that analyst conviction and institutional ownership support upside, although valuation metrics and reported insider selling are factors to monitor.

Analysis

AXQ Capital disclosed a new Q2 position in O’Reilly Automotive of 13,488 shares valued at about $1.216 million, joining several other small institutional purchases; institutional investors now own roughly 85% of the stock, indicating concentrated institutional positioning and recent inflows. The stock opened at $100.43, trading near its 50-day moving average of $100.62 and above the 200-day average of $97.33, with a market capitalization of $84.77 billion, a P/E of 34.79, PEG of 2.48 and a 52-week range of $78.30–$108.71, which implies the market is pricing above-average growth expectations. Analyst activity is broadly constructive: 19 buys versus 2 holds, DA Davidson and Goldman Sachs raised targets to $115 and $121 respectively, Raymond James upgraded to outperform, and MarketBeat’s consensus target is $111.89—implying roughly 11% upside from the current price. Insider activity introduces a cautionary signal: Director John R. Murphy sold 3,125 shares at $92.60 (a 27.78% reduction), insider ownership is only 1.01%, and Barclays’ equal-weight call shows that conviction is not unanimous, so monitor flow, valuation, and any further insider or analyst revisions as potential catalysts or risks.

Key Decisions for Investors

• Consider a selective add on weakness toward the 200-day moving average (~$97) given institutional positioning and a MarketBeat consensus target of $111.89 implying ~11% upside,
• Size new positions modestly because the stock trades at an elevated P/E (34.8) and PEG (2.48) that already reflects growth expectations,
• Monitor insider selling and any sustained decline in institutional ownership or negative analyst revisions and trim exposure if insider sales continue or the stock breaks materially below the 200-day MA,
• Use analyst target range ($111–$121) as a profit-taking guide and re-evaluate the position if the company fails to justify multiple expansion through concrete operational or earnings improvements